Cloning, characterization, and chromosomal mapping of a phospholipase (lecithinase) produced by Vibrio cholerae

Infection and Immunity

Volumn 65, Issue 8, 1997, Pages 3112-3117

  Fiore, Anthony E ^a,d   Michalski, Jane M ^a   Russell, Robert G ^b   Sears, Cynthia L ^c   Kaper, James B ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIAL ENZYME; CHOLERA VACCINE; PHOSPHOLIPASE;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CHOLERA; CHROMOSOME MAP; CONTROLLED STUDY; DELETION MUTANT; EGG YOLK; ENTERITIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; OPEN READING FRAME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; VIBRIO CHOLERAE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHROMOSOME MAPPING; CLONING, MOLECULAR; HT29 CELLS; HUMANS; LINKAGE (GENETICS); MALE; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHOLIPASES; RABBITS; VIBRIO CHOLERAE;

EID: 0030794595     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Alm, R. A., U. H. Stroeher, and P. A. Manning. 1988. Extracellular proteins of Vibrio cholerae: nucleotide sequence of the structural gene (hlyA) for the haemolysin of the haemolytic El Tor strain O17 and characterization of the hlyA mutation in the non-haemolytic classical strain 569B. Mol. Microbiol. 2:481-488.
2. Alm, R. A., G. Mayrhoger, I. Kotlarski, and P. A. Manning. 1991. Amino-terminal domain for the El Tor haemolysin of Vibrio cholerae O1 is expressed in classical strains and is cytotoxic. Vaccine 9:588-594.1.
3. Asnani, N., and P. J. Asnani. 1991. Structural and functional changes in rabbit ileum by purified extracellular phospholipase A of Salmonella newport. Folia Microbiol. 36:572-577.
4. Bennish, M. L. 1994. Cholera: pathophysiology, clinical features, and treatment, p. 229-255. In I. K. Wachsmuth, P. A. Blake, and Ø. Olksvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. American Society for Microbiology, Washington, D.C.
5. Brown, R. C., and R. K. Taylor. 1995. Organization of tcp, acf, and toxT genes within a ToxT-dependent operon. Mol. Microbiol. 16:425-439.
6. Butterton, J. R., J. A. Stoebner, S. M. Payne, and S. B. Calderwood. 1992. Cloning, sequencing, and transcriptional regulation of viuA, the gene encoding the ferric vibriobactin receptor of Vibrio cholerae. J. Bacteriol. 174:3729-3738.
7. Casanova, T. B., and K. M. Peterson. 1995. The Vibrio cholerae hlyC gene encodes a protein that is related to lipases of Pseudomonas species. DNA Seq. 5:181-184.
8. Comstock, L. E., J. M. Michalski, M. M. Levine, and J. B. Kaper. Unpublished data.
9. Daugherty, S., and M. G. Low. 1993. Cloning, expression, and mutagenesis of phosphatidylinositol-specific phospholipase C from Staphylococcus aureus: a potential staphylococcal virulence factor. Infect. Immun. 61:5078-5089.
10. Diener, M., C. Egleme, and W. Rummel. 1991. Phospholipase C-induced secretion and its interaction with carbachol in the rat colonic mucosa. Eur. J. Pharmacol. 299:267-276.
11. Felsenfeld, O. 1944. The lecithinase activity of Vibrio comma and the El Tor Vibrio. J. Bacteriol. 48:155-157.
12. Fujii, Y., and J. Sakurai. 1989. Contraction of the rat isolated aorta caused by Clostridium perfringens alpha toxin (phospholipase C): evidence for the involvement of arachidonic acid metabolism. Br. J. Pharmacol. 97:119-124.
13. Gangarosa, E. J., W. R. Beisel, C. Benyajati, H. Sprinz, and P. Piyaratn. 1960. The nature of the gastrointestinal lesion in Asiatic cholera and its relation to pathogenesis: a biopsy study. Am. J. Trop. Med. Hyg. 9:25-135.
14. Goldberg, M. B., S. A. Boyko, and S. B. Calderwood. 1991. Positive transcriptional regulation of an iron-regulated virulence gene in Vibrio cholerae. Proc. Natl. Acad. Sci. USA 88:1125-1129.
15. 2-mediated arachidonic acid release in cultured intestinal epithelium cells (INT 407). Scand. J. Gastroenterol. 29:243-247.
16. Honda, T., and R. A. Finkelstein. 1979. Purification and characterization of a hemolysin produced by Vibrio cholerae biotype El Tor: another toxic substance produced by cholera vibrios. Infect. Immun. 26:1020-1027.
17. Isakov, N. 1993. Activation of murine lymphocytes by exogenous phosphatidylethanolamine- and phosphatidylcholine-specific phospholipases C. Cell Immunol. 152:72-81.
18. Jones, B. D., and H. L. T. Mohley. 1987. Genetic and biochemical diversity of ureases of Proteus. Providencia, and Morganella species isolated from urinary tract infection. Infect. Immun. 55:2198-2203.
19. Kald, B., R.-M. Boll, C. Gustavson-Svard, R. Sjodahl, and C. Tagesson. 1994. Phospholipase C from Clostridium perfringens stimulates acetyltransferase-dependent formation of platelet-activating factor in cultured epithelial cells (INT 407). Scand. J. Gastroenterol. 29:243-247.
20. Kaper, J. B., H. L. T. Mohley, J. M. Michalski, D. A. Herrington, and M. M. Levine. 1988. Recent advances in developing a safe and effective live oral attenuated Vibrio cholerae vaccine, p. 161-167. In N. Ohtomo and R. B. Sack (ed.), Advances in research on cholera and related diarrheas, vol. 6. KTK Scientific Publishers, Tokyo, Japan.
21. Kaper, J. B. Unpublished data.
22. Levine, M. M., J. B. Kaper, D. Herrington, J. Ketley, G. Losonsky, C. O. Tacket, B. Tall, and S. Cryz. 1988. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet. ii:467-470.
23. Levine, M. M., and C. O. Tacket. 1994. Recombinant live cholera vaccines, p. 395-413. In I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. American Society for Microbiology, Washington, D.C.
24. Low, M. G. 1990. Degradation of glycosyl-phosphatidylinositol anchors by specific phospholipases. p. 35-63. In A. J. Turner, (ed.), Cell and molecular biology of membrane proteins. Ellis Horwood, Chichester, United Kingdom.
25. Michalski, J., J. E. Galen, A. Fasano, and J. B. Kaper. 1993. CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain. Infect. Immun. 61:4462-4468.
26. Miller, V. L., and J. J. Mekalanos. 1988. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J. Bacteriol. 170:2575-2583.
27. Mundy, L. M., and C. L. Sears. 1996. Detection of toxin production by Bacteroides fragilis: assay development and screening of extraintestinal clinical isolates. Clin. Infect. Dis. 23:269-276.
28. Nishihuchi, M., A. Fasano, R. G. Russell, and J. B. Kaper. 1092. Enterotoxigenicity of Vibrio parahaemolyticus with and without genes encoding thermostable direct hemolysin. Infect. Immun. 60:3539-45.
29. Peterson, J. W., and L. G. Ochoa. 1989. Role of prostaglandins and cAMP in the secretory effects of cholera toxin. Science 245:857-859.
30. Shaw, J.-F., R.-C. Chang, K.-H. Chuang, Y.-T. Yen, and F.-G. Wang. 1994. Nucleotide sequence of novel arylesterase gene from Vibro mimicus and characterization of the enzyme expressed in E. coli. Biochem. J. 298:675-680.
31. Shinoda, S., H. Matsuoaka, T. Tsuchie, S.-I. Miyoshi, S. Yamomnto, H. Taniguchi, and Y. Mizuguchi. 1991. Purification and characterization of a lecithin-dependent haemolysin from Escherichia coli transformed by a Vibrio parahaemolyticus gene. J. Gen. Microbiol. 137:2705-2711.
32. Silva, T. M. J., C. O. Tacket, J. H. Kaper, R. Edelman, M. Schleupner, and R. L. Guerrant. 1996. New evidence for an inflammatory component in diarrhea caused by selected new. live attenuated cholera vaccines and in El Tor and O139 cholera. Infect. Immun. 64:2362-2364.
33. Stoll, B. J., R. I. Glass, H. Banu, M. I. Huq, M. U. Khan, and M. Ahmed. 1983. Value of stool examination in patients with diarrhoea. Br. Med. J. 286:2037-2040.
34. Tacket, C. O., G. Losonsky, J. P. Nataro, S. J. Cryz, R. Edelman, A. Fasano, J. Michalski, J. B. Kaper, and M. M. Levine. 1993. Safety and immunogenecity of live oral cholera vaccine candidate CVD 110, a ΔctxA Δzot Δace derivative of El Tor Ogawa Vibrio cholerae. J. Infect. Dis. 168:1536-1540.
35. Tacket, C. O., G. Losonsky, J. P. Nataro, L. Comstock, J. Michalski, R. Edelman, J. B. Kaper, and M. M. Levine. 1995. Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J. Infect. Dis. 172:883-886.
36. Taniguchi, H., H. Ohta, O. Ogawa, and Y. Mizuguchi. 1985. Cloning and expression in Escherichia coli of Vibrio parahaemolyticus thermostable direct hemolysin and thermolabile genes. J. Bacteriol. 162:510-515.
37. Taniguchi, H., H. Hirano, S. Kobomura, K. Higashi, and Y. Mizuguchi. 1986. Comparison of the nucleotide sequences of the genes for the thermostable direct hemolysin and thermolabile hemolysin from Vibrio parahaemolyticus. Microb. Pathog. 1:425-432.
38. Thelestani, M., and R. Mollby. 1975. Sensitive assay for the detection of toxin-induced damage to the cytoplasmic membrane of human diploid fibroblasts. Infect. Immun. 12:225-232.
39. Thornton, J., S. P. Howard, and J. T. Buckley. 1988. Molecular cloning of a phospholipid-cholesterol acyltransferase from Aeromonas hydrophila. Sequence homologies with lecithin-cholesterol acyltransferases and other lipases. Biochim. Biophys. Acta. 959:153-159.
40. Titball, R. W. 1993. Bacterial phospholipases C. Microbiol. Rev. 57:347-366.
41. Trucksis, M., J. E. Galen, J. Michalski, A. Fasano, and J. B. Kaper. 1993. Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc. Natl. Acad. Sci. USA 90:5267-5271.
42. van Loon, F. P. L., G. H. Rabbani, K. Bukhave, and J. Rask-Madsen. 1992. Indomethacin decreases jejunal fluid secretion in addition to luminal release of prostaglandin E2 in patients with acute cholera. Gut 33:643-645.
43. von Heijne, G. 1985. Signal sequences. The limits of variation. J. Mol. Biol. 184:99-105.
44. Waldor, M. K., and J. J. Mekalanos. 1996. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272:1910-4.
45. Weikel, C. S., F. D. Grieco, J. Reuben, L. L. Myers, and R. B. Sack. 1992. Human colonic epithelial cells, HT29/C1, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology. Infect. Immun. 60:321-327.